Detalhe da pesquisa
1.
Does pharmacological castration as adjuvant therapy for prostate cancer after radiotherapy affect anxiety and depression levels, cognitive functions and quality of life?
Psychooncology
; 22(2): 346-51, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22081540
2.
What is the damage? Testicular germ cell tumour survivors deficient in testosterone at risk of metabolic syndrome and a need for medical intervention.
Med Oncol
; 37(9): 82, 2020 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32767179
3.
Clinical significance of androgen secretion disorders in men with a malignancy.
Med Oncol
; 34(7): 123, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28573637
4.
Dynamics of hormonal disorders following unilateral orchiectomy for a testicular tumor.
Med Oncol
; 34(5): 84, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28389909
5.
Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer.
Eur Urol
; 71(2): 168-171, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27522164
6.
Association of Survival Benefit With Docetaxel in Prostate Cancer and Total Number of Cycles Administered: A Post Hoc Analysis of the Mainsail Study.
JAMA Oncol
; 3(1): 68-75, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27560549